Diagnosing Zellweger Spectrum Disorder: The Diagnostic Journey and Its Market Impact
In ultra-rare diseases, diagnosis is destiny. For Zellweger spectrum disorder, the diagnostic journey has historically been long and uncertain — newborns with severe presentations may be identified quickly, but patients with milder forms often wait years for answers. Each diagnostic advance expands the identifiable patient population, and therefore the Zellweger spectrum disorder market....
0 Comments 0 Shares 115 Views 0 Reviews